INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,038,421 | -16.7% | 635,185 | -30.4% | 0.29% | -11.4% |
| Q2 2023 | $19,245,373 | +23.8% | 912,103 | 0.0% | 0.32% | +14.0% |
| Q1 2023 | $15,551,356 | +11.4% | 912,103 | +30.6% | 0.28% | +3.6% |
| Q4 2022 | $13,954,292 | +424.4% | 698,413 | +232.6% | 0.28% | +84.6% |
| Q1 2016 | $2,661,000 | -30.2% | 210,000 | 0.0% | 0.15% | -22.0% |
| Q4 2015 | $3,812,000 | +42.0% | 210,000 | +45.2% | 0.19% | +22.4% |
| Q3 2015 | $2,685,000 | +24.1% | 144,600 | +63.2% | 0.16% | +33.3% |
| Q2 2015 | $2,164,000 | +17.4% | 88,600 | 0.0% | 0.12% | -15.8% |
| Q1 2015 | $1,843,000 | +34.4% | 88,600 | 0.0% | 0.14% | -7.3% |
| Q4 2014 | $1,371,000 | +18.6% | 88,600 | 0.0% | 0.15% | -6.8% |
| Q3 2014 | $1,156,000 | -34.7% | 88,600 | 0.0% | 0.16% | -33.2% |
| Q2 2014 | $1,770,000 | +29.1% | 88,600 | +23.1% | 0.24% | +13.1% |
| Q1 2014 | $1,371,000 | +144.8% | 72,000 | +118.8% | 0.21% | +23.1% |
| Q4 2013 | $560,000 | – | 32,900 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
| Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
| NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
| Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
| Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
| ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
| Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
| Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
| EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |